Showing 1 - 2 results of 2 for search 'Oliver Tome', query time: 0.01s Refine Results
  1. 1
    Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effectsResearch in context

    Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effectsResearch in context by Deeksha Malhan, Janina Hesse, Nina Nelson, Kay Stankov, Jessica Nguyen, Ouda Aboumanify, Josefin Garmshausen, Gunther Rogmans, Bastian Czogalla, Jens Gerber, Martin Koch, Tomáš Kupec, Oliver Tomé, Ralf Witteler, Mustafa Deryal, Michael Eichbaum, Jalid Sehouli, Elena Ioana Braicu, Angela Relógio

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer – the SERAPHINA study

    The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer – the SERAPHINA study by Andreas Schneeweiss, Peter A. Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Hans Tesch, Tanja N. Fehm, Tjoung-Won Park-Simon, Lothar Häberle, Sabrina Uhrig, Oliver Tome, Thomas Spall, Anna-Katharin Theuser, Matthias Ruebner, Erik Belleville, Diethelm Wallwiener, Sara Y. Brucker, Andreas D. Hartkopf

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: